DEC 14, 2017 6:40 AM PST

Typhoid Fever Toxin Targets Sugary Cells

WRITTEN BY: Kara Marker

A new study from Cornell University explains why the current vaccine for typhoid fever is only partially effective. Salmonella typhi, the bacterial agent responsible for the disease, has eluded scientists aiming to decipher its molecular mechanisms of infection, but the new study, published in the journal Nature Microbiology, uncovers several important details.

Colorized scanning electron micrograph of the foodborne pathogen Salmonella enteritidis, the most common in the United States alongside Salmonella typhimurium.

Even in the 21st century, typhoid fever continues to spread as a result of poor sanitation, affecting over 21 million people worldwide. A typhoid fever infection, which is preventable and treatable with antibiotics, causes symptoms such as fever, weakness, stomach pains, headache, and loss of appetite. Salmonella typhi only lives in humans, carried in the bloodstream and intestinal tract and discarded in feces. The bacteria can live both inside and outside the cells it infects.

When Salmonella typhi live inside cells, they produce the typhoid toxin, which then generates the symptoms characteristic of typhoid fever. The current vaccine for typhoid fever, a drug called Typhoid Vaccine Live Oral Ty21a, is effective against the bacteria but not the toxin.

How does the typhoid toxin work? It searches for cells to intoxicate that express specific sugars, for their binding abilities. This attraction to sugar leads scientists to think that there’s a possibility of intervening at this level.

"Intriguingly, our study shows that the typhoid toxin targets both the immune system and central nervous system," explained senior author Jeongmin Song. "This represents a new paradigm in the infectious agents' incursion of the host."

Song and his team are looking at new, sugar-based treatment options to combine with Ty21a instead of just applying Ty21a alone. This approach could also work for other diseases where microorganisms are attracted to sugars for their binding capabilities.

"What's most exciting is that our results provide insights that may help the development of potential prophylactics and therapeutics to prevent and treat typhoid fever," Song explained.

Sources: CDC, Cornell University

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
APR 01, 2021
Immunology
The Curious Case of COVID Immunity...a Threat to Vaccination Efforts?
APR 01, 2021
The Curious Case of COVID Immunity...a Threat to Vaccination Efforts?
After COVID infection, there’s a spectrum of diversity in how long antibodies against the coronavirus hang around& ...
APR 13, 2021
Immunology
The "Unexpected" Reason Why COVID Antivirals Don't Work
APR 13, 2021
The "Unexpected" Reason Why COVID Antivirals Don't Work
Purdue University researchers have made a breakthrough finding that could explain why the disease is so hard to manage t ...
APR 21, 2021
Health & Medicine
Topical Probiotics Are a Beneficial Acne Treatment
APR 21, 2021
Topical Probiotics Are a Beneficial Acne Treatment
Research underway is showing topical probiotics to be a beneficial treatment for acne vulgaris. Topical probiotics are a ...
MAY 11, 2021
Immunology
Immune Cells Help Brain Tumors Spread, but We Can Stop Them
MAY 11, 2021
Immune Cells Help Brain Tumors Spread, but We Can Stop Them
Researchers have discovered how a glitch in the brain’s immune system can inadvertently cause an accelerated growt ...
MAY 11, 2021
Genetics & Genomics
Gene Therapy Trial for Severe Immune Disorder is Successful
MAY 11, 2021
Gene Therapy Trial for Severe Immune Disorder is Successful
Severe combined immunodeficiency (SCID), which virtually eliminates a patient's immune system, and severely affects thei ...
JUL 06, 2021
Immunology
New Nanotechnology Delivers RNA Drugs Only to "Bad" Immune Cells
JUL 06, 2021
New Nanotechnology Delivers RNA Drugs Only to "Bad" Immune Cells
Inflammatory conditions are linked to an overactive immune system, and resolving them therapeutically often involves cal ...
Loading Comments...